Search Press releases Keywords From To 24 Aug 2021 UCB Announces European Commission Approval of BIMZELX[®]▼ (bimekizumab) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More 20 Aug 2021 Disposals of own shares Read More 13 Aug 2021 Disposals of own shares Read More 9 Aug 2021 Transparency notification FMR LLC. Read More 7 Aug 2021 New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis Read More 6 Aug 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 43 Page 44 Page 45 Page 46 Current page 47 Page 48 Page 49 Page 50 Page 51 … Page 47 of 68 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
